88IV - PR Newswire Asia's news - Health Care/Hospital

< Previous page

| Title only | Print

Next page >

Innogen Pharmaceutical Group Highlights China-Originated Innovation and Global Development Strategy at DIA Global Annual Meeting 2026 China Town Hall From original GLP-1 science to international clinical development, Innogen shares its "from 0 to 1" innovation journey in metabolic diseases ... 2026-06-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
STARTRADER Delivers Emergency Relief to 300 Earthquake-Affected Families in the Philippines Aid initiative supports families in Sarangani Province following the 7.8-magnitude earthquake, reinforcing the importance of collective action during times of crisis. ... 2026-06-22T Banking/Financial Service Health Care/Hospital
Translational Research Results of Sacituzumab Tirumotecan (sac-TMT) in Combination with Osimertinib as First-Line Treatment for EGFR-Mutant NSCLC Published in Cancer Cell — The study shows that EGFR-TKIs induce TROP2 upregulation in DTP cells, providing a mechanistic basis for combining sac-TMT with EGFR-TKI. ... 2026-06-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Medicine And SK Biopharmaceuticals Achieved AI-powered Drug Discovery Collaboration Worth Up to 2.5 Billion for Neuroimmune Disorders CAMBRIDGE, Mass. , June 22, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK ), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and SK Biopharmaceuticals, ... 2026-06-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
FDA Clears PanopticAI's Contactless Respiratory Rate Measurement Following the startup's first FDA 510 (k) clearance for its contactless pulse rate monitoring, PanopticAI has now secured a second one for respiratory rate measurement. This milestone cements its position ... 2026-06-22T Computer Software Computer/Electronics Health Care/Hospital Medical Equipment
Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE ATG-106 is a first-in-class CDH6 x CD3 bispecific T cell engager (TCE) in preclinical development for the treatment of solid tumors K2 Therapeutics, established by MPM BioImpact, ... 2026-06-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use INCHEON, South Korea and SAN DIEGO , June 22, 2026 /PRNewswire/ -- LOTTE Biologics announced that it has completed major construction and obtained approval for use for Plant 1 at its Songdo Bio ... 2026-06-22T Biotechnology Construction/Building Health Care/Hospital
Allianz Partners Responds to Cost Living Crisis with refreshed Overseas Visitor Health Cover for Australia's International Workers BRISBANE, Australia , June 22, 2026 /PRNewswire/ -- Allianz Care, part of global leader in insurance and assistance services Allianz Partners , has unveiled a refreshed Overseas Visitor Health ... 2026-06-22T Banking/Financial Service Health Care/Hospital
Murj® Expands Global Footprint with Commercial Launch in Australia and New Zealand SYDNEY and AUCKLAND, New Zealand , June 22, 2026 /PRNewswire/ -- Murj ® , a cardiac device management software company, today announced its official expansion into the Australian market alongside ... 2026-06-22T Computer Software Computer/Electronics Health Care/Hospital Medical Equipment
Pope Leo XIV embraces paediatric patients at CNAO in Pavia PAVIA, Italy , June 20, 2026 /PRNewswire/ -- The National Center for Oncological Hadrontherapy (CNAO) served as the first stop today during Pope Leo XIV's pastoral visit to the city of Pavia. His choice ... 2026-06-20T Computer/Electronics Health Care/Hospital

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved